Trials / Conditions / Giant Lymph Node Hyperplasia
Giant Lymph Node Hyperplasia
7 registered clinical trials studyying Giant Lymph Node Hyperplasia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | International Registry for Patients With Castleman Disease NCT02817997 | University of Pennsylvania | — |
| Withdrawn | Castleman Disease Collaborative Network Biobank NCT02871050 | Castleman Disease Collaborative Network | — |
| Completed | Unlock the Cell: Castleman's Disease Flow Cytometry Study NCT02853968 | University of Pennsylvania | — |
| Completed | Tocilizumab for KSHV-Associated Multicentric Castleman Disease NCT01441063 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease NCT00361933 | University of Washington | Phase 4 |
| Completed | A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or C NCT00412321 | Centocor, Inc. | Phase 1 |
| Terminated | Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy NCT00127569 | French National Agency for Research on AIDS and Viral Hepatitis | Phase 2 |